-
Loading metrics
Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer
- Alberto Peláez-García,
- Laura Yébenes,
- Alberto Berjón,
- Antonia Angulo,
- Pilar Zamora,
- José Ignacio Sánchez-Méndez,
- Enrique Espinosa,
- Andrés Redondo,
- Victoria Heredia-Soto,
- Marta Mendiola,
- Jaime Feliú,
-
David Hardisson
Roles Conceptualization, Formal analysis, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing
* E-mail: david.hardisson@salud.madrid.org
Affiliations Department of Pathology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain, Molecular Pathology and Therapeutic Targets Group, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain, Molecular Pathology Diagnostic Unit, Hospital Universitario La Paz, INGEMM, IdiPAZ, Madrid, Spain, Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain
⨯
http://orcid.org/0000-0002-2183-3699
Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer
- Alberto Peláez-García,
- Laura Yébenes,
- Alberto Berjón,
- Antonia Angulo,
- Pilar Zamora,
- José Ignacio Sánchez-Méndez,
- Enrique Espinosa,
- Andrés Redondo,
- Victoria Heredia-Soto,
- Marta Mendiola
x
- Published: September 8, 2017
- https://doi.org/10.1371/journal.pone.0183452